ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Charge Capacitive Signatures at the Interface of E. coli/MOF Biohybrids to Create a Live Cell Biocapacitor.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Designing Microbe-Semiconductor Interfaces for Semibiological Photosynthesis.Chemical reviews · 2026Review
- An innovative diagnostic method for myopia using blood-based biomemristor.Materials today. Bio · 2025Article
- Charge Capacitive Signatures at the Interface of E. coli/MOF Biohybrids to Create a Live Cell Biocapacitor.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The chemistry of the extracellular electron transfer (EET) process in microorganisms can be understood by interfacing them with abiotic materials that act as external redox mediators. These mediators capture and transfer extracellular electrons through redox reactions, bridging the microorganism and the electrode surface. Understanding this charge transfer process is essential for designing biocapacitors capable of modulating and storing charge signatures as capacitance at the electrode interface. Herein, a novel biointerfacial strategy is presented to investigate directional charge injection from a non-exoelectrogenic living microbe to an electrode surface using the porous metal-organic framework (MOF), MIL-88B. The biohybrid, formed by interfacing Escherichia coli (E. coli) with MIL-88B, demonstrates symbiotic interactions between the biotic and abiotic components, facilitating EET from E. coli to the electrode via the MOF. Acting as a redox mediator, the MOF catalyzes E. coli's exoelectrogenic activity, generating distinct charge capacitive signatures at the E. coli-MOF interface. This system integrates the capacitive signatures resulting from the EET process with the MOF's intrinsic pseudocapacitive properties and surface-controlled capacitive effects, functioning as a highly efficient biocapacitor. Furthermore, this approach of converting the biochemical energy of a non-exoelectrogenic microorganism into capacitive signatures opens a new pathway for translating biological signals into functional outputs, paving the way for autonomous biosensing platforms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.